Overtreatment of prostate cancer in the active surveillance era
Common Sense Family Doctor
DECEMBER 14, 2024
Concerns about overdiagnosis of clinically insignificant prostate cancer through prostate specific antigen (PSA) screening motivated the 2018 American Academy of Family Physicians’ (AAFP) recommendation against routine screening for prostate cancer. Explaining the AAFP’s position, Drs. James Stevermer and Kenneth Fink wrote in an AFP editorial : Few men diagnosed with and treated for prostate cancer will experience a mortality benefit, and an estimated 20% to 50% of those treated will never beco
52 
Let's personalize your content